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Computational Biology, Department of Biology, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany
The dimerization or even oligomerization of G protein coupled receptors (GPCRs)
causes ongoing, controversial debates about its functional role and the coupled
biophysical, biochemical or biomedical implications. A continously growing number
of studies hints to a relation between oligomerization and function of GPCRs and
strengthens the assumption that receptor assembly plays a key role in the regulation
of protein function. Additionally, progress in the structural analysis of GPCR-G
protein and GPCR-ligand interactions allows to distinguish between actively functional
and non-signaling complexes. Recent findings further suggest that the surrounding
membrane, i.e., its lipid composition may modulate the preferred dimerization interface
and as a result the abundance of distinct dimeric conformations. In this review, the
association of GPCRs and the role of the membrane in oligomerization will be discussed.
An overview of the different reported oligomeric interfaces is provided and their capability
for signaling discussed. The currently available data is summarized with regard to the
formation of GPCR oligomers, their structures and dependency on the membrane
microenvironment as well as the coupling of oligomerization to receptor function.
Keywords: GPCR, dimerization, oligomerization, membrane, cholesterol, palmitoylation, FRET, molecular
dynamics simulation
1. INTRODUCTION
G protein coupled receptors (GPCRs) form the largest and most diverse group of transmembrane
proteins and are considered key players involved in numerous processes, including in particular
the communication between cells. The membrane-embedded portion of all GPCRs is built by seven
transmembrane helices (TM1-TM7). Upon activation they couple to a G protein at the intracellular,
carboxyl-terminal part. The activation-inducing ligand is received from the extracellular domain of
the receptor. For both, ligands andG proteins, GPCRs typically show a high plasticity with regard to
engaging with different types of interaction partners, hence a single GPCR can be involved in many
different signaling pathways. Even though GPCRs have been studied for several decades, certain
aspects of their function still lack a complete characterization. Until the early 2000s, GPCRs were
considered as functional monomeric units. However, a continuously growing number of studies
reported the presence of homo- or heterodimers or even higher-order oligomers throughout the
vast family of these receptors (Angers et al., 2002). The importance of receptor assembly is still
debated: On the one hand, different studies present evidence that dimerization is required prior of
signaling, especially for the group of class C GPCRs (Kniazeff et al., 2011). On the other hand, for
the overall less investigated class B GPCRs, functional monomers were shown by actively disrupting
dimerization by mutations (Pioszak and Xu, 2008). Still, there is rising evidence that these receptor
types form also functional dimers (Ng et al., 2012).
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Similar findings were reported for the medically most
relevant and largest group of class A GPCRs: Evidence has been
collected for both, functional monomers as well as functional
dimers or oligomers. For example signaling monomers have
been reported for rhodopsin (Bayburt et al., 2007) and the
β2-adrenergic receptor (Whorton et al., 2007), while the same
receptors have been observed in dimeric configurations in
crystal structures (Palczewski et al., 2000; Cherezov et al., 2007).
Additionally, other experiments also hint to functional dimers
of these receptors (Angers et al., 2000; Jastrzebska et al., 2015).
In general, the ongoing development and improvement of
membrane protein crystallography allowed to resolve several
crystal structures of GPCRs (Ghosh et al., 2015), frequently
with the receptors in stable dimeric conformations (Rosenbaum
et al., 2009; Katritsch et al., 2012). However, crystal dimer
configurations may not necessarily reflect native dimer
configurations, since the crystallization may require sequence
modifications and in particular since the crystal environment
differs considerably from the membrane environment in vivo. In
addition to the growing number of structures, more and more
computational methods were employed to unveil the dynamics
of GPCR multimerization (Meng et al., 2014; Kaczor et al.,
2015). The functionality of GPCR dimers was further validated
by advanced fluorescence methods such as Förster resonance
energy transfer (FRET), bioluminescence resonance energy
transfer (BRET), or fluorescence correlation spectroscopy (FCS)
experiments, which allow to measure signaling and aggregation
of GPCRs simultaneously (Goddard andWatts, 2012a; Kasai and
Kusumi, 2014; Vischer et al., 2015).
Based on the continuously growing number of studies
indicating class A GPCR assembly as a part of proper signaling,
the process of dimer formation and differences in dimer
interfaces among different GPCRs shifted into the focus.
Recent cross-linking studies revealed that active GPCRs may
form dimer interfaces that differ from that of their inactive
conformation (Guo et al., 2005; Mancia et al., 2008). These
intriguing shifts in GPCR dimerization interfaces suggest its
involvement in the regulation of GPCR activation and signaling
strength.
Structural studies revealed that GPCRs share a typical
conformational change upon activation. This configurational
transition mainly involves an outwards movement of TM6,
opening up the intracellular part of the TM helix bundle in order
to enable G protein coupling (Kobilka, 2007; Kimata et al., 2015).
In addition to this commonly observed conformational change,
functional selectivity of the serotonin 5-Hydroxytryptamine(2A)
(5-HT2A) receptor was assigned to smaller yet specific ligand-
dependent conformational changes of the intracellular loop
2 (connecting TM3 and TM4) (Perez-Aguilar et al., 2014).
These observations allow to hypothesize that the modulation of
dimeric or oligomeric interfaces may contribute to the functional
selectivity by inducing or hindering specific conformational
changes. For instance, involvement of TM6 at the dimer interface,
may possibly result in conformational trapping of TM6 in
an activation-incompetent conformation (Cordomí et al., 2015;
Vafabakhsh et al., 2015). Vice versa, active receptor dimer
configurations will likely require a conformationally flexible TM6
helix, i.e., a dimer interface without TM6 (e.g., a symmetric
interface around TM1 and TM4). Such a dimer-specific activity
and functional selectivity could offer new opportunities to target
GPCR function with medical drugs (Hipser et al., 2010).
Furthermore, an increasing number of studies suggests that
dimerization and signaling of GPCRs are modulated by the
surrounding membrane. This review will focus on how different
types of lipids and other membrane components may influence
dimerization patterns of GPCRs and thereby possibly regulate
function and signaling. There are two possible paths for how
lipids may influence GPCRs association: by direct binding to
the receptor surface, or indirectly by modulating the properties
of the surrounding membrane. Here, we review and discuss
available information for both mechanisms, as well as commonly
employed methods for the study of GPCR oligomerization.
2. METHODS TO ANALYZE GPCR
OLIGOMERIZATION
Two frequently used methods to analyze GPCR dimer- or
oligomerization are resonance energy transfer (RET) techniques
and computational approaches such as molecular dynamics
(MD) simulations. In FRET and BRET experiments, the
resonance energy transfer between an energy donor and an
energy acceptor is used to analyze protein association (Cottet
et al., 2012). The efficiency of this non-radiative energy
transfer (via long-range dipole-dipole interactions) is inversely
proportional to the sixth power of the distance between donor
and acceptor (Förster, 1948). In general RET methods have
a spatial resolution of 10–100Å (Sekar and Periasamy, 2003).
FRET studies are performed by fusing fluorescent proteins to
the C-terminal parts of the GPCRs of interest. The fluorescent
proteins are usually variants of the green fluorescent protein
(GFP) (Shimomura et al., 1962) that show a certain overlap of
their excitation and emission spectra (e.g., CFP and YFP), in
order to allow for the absorption of the donor-emitted light by
the acceptor.
Due to the fact that the fluorophor proteins consist of
approximately 230 amino acids, hence are of comparable size
as GPCRs themselves, the receptor stability needs to be tested
and possible fluorophor-driven associations between the proteins
should be excluded (see e.g., Lohse et al., 2012). As an alternative
to the large GFP, small peptides binding extracellular fluorescein
were presented that may in many cases reduce steric side
effects (Griffin et al., 1998).
If the donor is excited via light waves at its absorbance
wavelength and the acceptor is in close vicinity, FRET occurs
between the donor and the acceptor resulting in a detectable
emission of light from the acceptor (see Figure 1). However, not
only the distance but as well the relative orientations between
donor and acceptor affect the energy transfer: If the dipoles are
oriented perpendicular to each other, no FRET occurs. Only a
parallel orientation between donor and acceptor dipoles allows
for a resonance energy transfer. Further the efficiency of the
energy transfer between FRET proteins is rather small (about
10–40%), hence only small fluorescence intensities have to be
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FIGURE 1 | Model of FRET experiments applied to GPCR dimerization. The GPCR (here: CXCR4 chemokine receptor, PDB: 3ODU, Wu et al., 2010) is shown in
surface and cartoon representation and colored in a lateral gradient from red to green. Fluorescent proteins (PDB: 1YFP, Wachter et al., 2000) are linked to the
C-terminal part of the crystal structures. CFP is shown in cyan, unexcited YFP in gray and YFP in its excited state in yellow (Figure inspired by Lohse et al., 2012;
Broussard et al., 2013).
measured which can be quite challenging (Broussard et al.,
2013). Therefore, experimental instruments need to be justified
carefully and extensive mathematical analysis of the collected
signals is required for reliable conclusions. Additionally, the
absence of FRET is not equivalent to the absence of protein-
protein interactions, the fluorophors might not be in a close
enough proximity or their relative dipole orientation might not
be properly aligned, i.e., the proteins formed a FRET-negative
configuration. Furthermore, the surrounding environment can
quench the fluorescence up to a degree that no FRET signals
can be detected. On the other hand, the overexpression
of fluorescence proteins or high protein concentrations can
lead to FRET between non-interacting proteins in close
vicinity.
In BRET assays, a bioluminescent protein (e.g., luciferase
from Renilla reniformis, Rluc) is used as the donor, i.e., no
light excitation of the donor is required but a substrate
(e.g., coelenterazine h for Rluc) in order to stimulate the
bioluminescence. Rluc can serve as a donor with YFP or GFP as
the acceptor (Ayoub and Pfleger, 2010). The basic advantages of
BRET techniques are the reduced background signal as compared
to FRET methods, since the excitation is biochemically triggered
instead of light-induced. Additionally, BRET enables to perform
kinetical measurements, given that the signals can be detected for
up to 30min (Cottet et al., 2012). A notable drawback of BRET
strategies as compared to FRET techniques is that the substrate
not only excites the bioluminescent proteins at the cell surface
but possibly as well cell-interior proteins.
FRET and BRET techniques are very powerful tools to
investigate protein association, however the interpretation of
RET efficiencies can be rather challenging because different
efficiencies can result from either an increased or decreased
number of receptor oligomers or from conformational
changes in preexisting complexes (see Figure 1). Nevertheless,
conformational changes can be concluded if the maximal RET
changes while the RET50 value (acceptor/donor ratio resulting in
a half maximal RET signal) remains unaffected, indicating that
the relative affinity between the acceptor and the donor remained
equal (Percherancier et al., 2005; Szidonya et al., 2008).
MD simulations provide atomistic detail of biomolecular
processes at high spatial and time resolution and proved
extremely useful in the study of GPCR dynamics, GPCR oligomer
formation and in the analysis of the influence of the membrane
environment on oligomerization (Sabbadin et al., 2014; Sengupta
and Chattopadhyay, 2015; Tautermann et al., 2015). In general,
MD simulations at atomistic resolution of biomolecular systems
are limited to the timescale of hundreds of nanoseconds to
a few microseconds. However, protein aggregation occurs on
timescales of tens of microseconds. Additionally, membrane
systems typically contain more than 100,000 atoms and are
therefore computationally rather expensive. Therefore, atomistic
MD simulations can hardly be employed in the study GPCR
association.
A significant speedup is gained by switching to more coarse-
grained resolutions. For example, in the widely used Martini
coarse-grained (CG) model, four heavy atoms are grouped
together in one superatom (or bead) that reflects the properties
of the 4 atoms (Marrink et al., 2004, 2007; Monticelli et al., 2008)
(see Figure 2). In this way, the number of degrees of freedom is
reduced, high frequencymotions of hydrogen atoms are excluded
and the diffusion of proteins is increased by a reduced friction
between CG beads as compared to atoms. Taken together, the
computation time required to study a biomolecular process at
CG resolution is by 100–500 times reduced as compared to a
corresponding atomistic simulation.
Of course this loss of resolution comes with several drawbacks
as compared to atomistic simulations. One important aspect in
this regard is the inability of the CG force field to describe
conformational changes of proteins, which is due to the
simple design of the protein backbone in the Martini force
field (Marrink and Tieleman, 2013). In fact, the secondary
structure is constrained by an additional force network to keep
a preset structure (de Jong et al., 2012). In addition, the reduction
of resolution also affects the energy landscape of molecular
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FIGURE 2 | Coarse-grained MD simulations. (A) Several molecules are shown as overlays between the atomistic and the corresponding Martini coarse-grained
models. (B) A typical coarse-grained simulation system as used in receptor dimerization is shown before and after the simulation (Pluhackova et al., 2016).
systems: free solvation energies can be reproduced quite
accurately in CG systems as compared to atomistic simulations,
however, the decomposition of these free energies into enthalpic
and entropic contributions can differ strongly (Marrink and
Tieleman, 2013). The reduction of the number of degrees of
freedom influences the entropy of the system. In order to
reproduce the correct free energy, the enthalpic energies are
therefore increased in the Martini model. In the same context,
electrostatic interactions between charged particles are described
implicitly in order to compensate the reduced number of partial
charges and dipoles as compared to atomistic force fields.
Consequently, Coulombic interactions in apolar environments
are too weak in CG Martini models (Marrink and Tieleman,
2013).
Additionally, interactions between proteins in aqueous
solution (Stark et al., 2013; Larisch et al., 2016), membrane-
embedded proteins (Prakash et al., 2010; Chavent et al.,
2014), as well as between peptides and the membrane
interface (Pluhackova et al., 2015) using the standard Martini
force field were shown to be artificially enhanced, in particular for
the original Martini force field for proteins (Prakash et al., 2010;
Stark et al., 2013; Chavent et al., 2014). As a cure, it was shown
for the older variant of the Martini force field that a reduction
of the Lennard-Jones interactions between protein beads may
compensate this overestimation (Stark et al., 2013).
Nonetheless, the Martini forcefield shows good performance
for membrane systems, hence it is commonly used to investigate
transmembrane proteins on long timescales (Pluhackova et al.,
2013; Pluhackova and Böckmann, 2015). GPCR association is
usually addressed by simulating a CG system that contains
several copies of the receptor, embedded in a membrane bilayer
for up to tens of microseconds (Provasi et al., 2015). In this
way, different dimeric interfaces can be identified from one
simulation. However, the method is hampered by the low
dissociation rate, i.e., dimers were not observed to dissociate
again on the accessible simulation timescale (Prasanna et al.,
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2014; Provasi et al., 2015). The obtained statistics from only a few
of such simulations is thus quite limited.
A recently developed high-throughput simulation
method termed DAFT (Docking Assay For Transmembrane
components) offers an automated, extensive sampling of
different GPCR dimerization interfaces (Wassenaar et al., 2015b;
Pluhackova et al., 2016). In this methodology, several hundreds
of CG simulations are performed, each consisting of two copies
of a GPCR embedded in an explicit membrane environment
and surrounded by water (Wassenaar et al., 2015a). The two
proteins are initially placed at a fixed starting distance from each
other, but at different starting orientations. Using this ensemble
simulation setup, allows to gain statistical insight into GPCR
dimerization patterns and how changes in the lipid environment
alter the protein association. Despite the aforementioned
possible overestimation of protein-protein interactions, the
DAFT approach in combination with the Martini force
field (de Jong et al., 2012) allowed to determine preferred dimer
interfaces for different systems that are in excellent agreement
with experiments (Han et al., 2015; Wassenaar et al., 2015b;
Pluhackova et al., 2016).
3. COMPARTMENTALIZATION OF GPCRS
IN MEMBRANE NANODOMAINS
Possible membrane-driven mechanisms that influence the
dimerization or oligomerization of GPCRs will sensitively
depend on the membrane environment around the receptors.
Further, the lipid environment was shown to influence GPCR
function and several health disorders during aging were assigned
to changes in the membrane composition that altered GPCR
signaling (Alemany et al., 2007). The colocalization of GPCRs
and other components involved in signal propagation in dynamic
membrane nanodomains (sometimes referred to as lipid rafts)
has been reported in a vast number of studies (Goddard
et al., 2013). These nanodomains are characterized as densely
packed, dynamic membrane areas with increased concentrations
of glycosphingolipids and cholesterol and have been indicated
to play important roles in the sorting and organization of
membrane proteins (Villar et al., 2016). Caveolae (“little
caves”) show a similar lipid composition, but they additionally
contain the protein caveoline on the inner leaflet of the
bilayer (Insel et al., 2005). GPCR signaling involves many
components like heterotrimeric G proteins (consisting of Gα ,
Gβ , and Gγ subunits), adenylyl cyclases, channel proteins,
phospholipases or GTP exchange factors (Ostrom and Insel,
2004). Signal transduction is mainly performed by specific,
physical interactions between these components. However,
GPCRs, G proteins and other effector enzymes have been
reported to be expressed at low concentrations in cells (Ostrom
et al., 2000), thus suggesting a selective compartmentalization
of the involved molecules as necessary for efficient signaling.
Obviously, the compartmentalization of GPCRs would as well
increase the probability for GPCR oligomerization.
Colocalization of GPCRs in caveolae was determined for
several GPCRs mainly by comparing fluorescence profiles of
caveolin proteins with profiles of marked receptors (Head et al.,
2005; Insel et al., 2005). In some cases the receptors colocalized in
these domains before any stimulations by an agonist (e.g., β1AR
and β2AR Schwencke et al., 1999; Xiang et al., 2002, serotonin 5-
HT2A receptor Bhatnagar et al., 2004, orµ-opiod receptorHuang
et al., 2007), in other experiments it was observed that the
colocalization is agonist-induced (e.g., angiotensin II type 1
receptor Ishizaka et al., 1998, kinin B1 receptor Sabourin et al.,
2002, or gonadotropin-releasing hormone receptor Pawson et al.,
2003). Furthermore, multiprotein complexes involving the β2AR
were observed in caveolin-rich areas of the membrane (Ianoul
et al., 2005).
Non-caveolar nanodomains were also shown to organize
GPCRs and regulate their signaling and oligomerization (Xu
et al., 2006; Fallahi-Sichani and Linderman, 2009; Villar
et al., 2016). A study on the G protein coupled purinergic
P2Y12 receptor showed that disruption of functional oligomers,
which are incorporated in membrane nanodomains, into non-
functional dimers or monomers leads to partitioning of the
receptors out of the lipid rafts (Savi et al., 2006). Oligomerization
may thus be required for correct localization in membrane
nanodomains important for proper signaling.
4. HYDROPHOBIC MISMATCH PROMOTES
RECEPTOR ASSEMBLY
An evident mechanism how membrane properties may
regulate GPCR assembly in membrane nanodomains is due
to hydrophobic forces coupled to a hydrophobic match or
mismatch. The hydrophobic mismatch is defined as the
difference between the hydrophobic membrane thickness and
the peripheral length of the hydrophobic part of the membrane-
spanning protein. Consequently, if the protein’s hydrophobic
part exceeds the bilayer thickness, oligomerization might
reduce the exposed hydrophobic area of the protein (Killian,
1998) (see Figure 3). Using FRET experiments it was
shown that the reduction of membrane thickness or the
increase of the protein/lipid molar ratio promote rhodopsin
association (Botelho et al., 2006). This observation was assumed
to be based on the hydrophobic mismatch induced curvature
of the membrane at the protein-lipid interface. Association
of proteins into protein clusters relieves the curvature free
energy (Botelho et al., 2006).
Association of GPCRs to improve the hydrophobic match
was additionally analyzed using computational methods to gain
molecular insight in this process (Li et al., 2012; Sadiq et al., 2013;
Rog and Vattulainen, 2014). Performing coarse-grained MD
simulations on systems containing several copies of rhodopsin
embedded in membranes of different thickness, it was shown
that rhodopsin alters the membrane thickness at the membrane-
protein interface (Periole et al., 2007). The shorter the lipid chain
length, the more pronounced was the hydrophobic mismatch
induced deformation of the bilayer. Local thickening of the
membrane was observed near the transmembrane (TM) helices
2, 4, and 7 while thinning was reported near TM1, TM5,
TM6, and helix 8 (H8). The most frequently observed dimer
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FIGURE 3 | Influence of the hydrophobic mismatch on membrane-protein systems. The GPCR (A2A adenosine receptor, PDB entry 4EIY, Liu et al., 2012b) is
shown in surface representation and colored according to its hypothetical hydrophobicity (red, hydrophobic membrane-embedded portion; blue, hydrophilic,
solvent-exposed region). Due to protein insertion, the hydrophobic mismatch induces stress and curvature in the membrane (purple areas in the membrane). In order
to reduce membrane stress, the proteins can associate (upper right) or move to membrane areas of increased thickness, e.g., membrane areas with higher cholesterol
content (green, lower right). For models on protein-lipid interactions and the hydrophobic match/mismatch please see Kralchevsky et al. (1995) and Mouritsen (2013).
conformations were formed by symmetric TM1,2,H8/TM1,2,H8,
TM4/TM5, or TM6/TM7 interactions. Overall, oligomerization
was enhanced in membranes consisting of lipids with shorter
chain length (Periole et al., 2007). Another computational
investigation was reported for the adrenergic receptors β1AR
and β2AR. The aim was to predict oligomerization interfaces
by analyzing the residual hydrophobic mismatch (RHM,
contributions to the energy penalty associated to particular
residues) (Mondal et al., 2013). Notably, it was observed
that TM1, TM4, and TM5 were most frequently involved in
receptor-receptor interactions and showed the highest RHM
in monomers which was substantially alleviated in oligomers.
Interestingly, in spite of the similarity in sequence and structure,
the β1AR showed by far the highest RHM for TM1, while
TM4 and TM5 revealed a much smaller RHM as compared
to β2AR. Earlier experiments revealed that β1AR indeed
mainly dimerized via TM1/TM1 interactions (Calebiro et al.,
2013). Inclusion of 10% cholesterol in the membrane overall
decreased the RHM, probably by increasing the membrane
thickness by inducing an increased order to the lipids’
fatty acid chains (de Meyer and Smit, 2009; Mondal et al.,
2011).
A few experimental studies addressed the relation between
membrane thickness and receptor activity. A more disperse
membrane, consisting of diverse lipid types, possibly enabling
different membrane domains of different thickness, was
shown to facilitate the formation of the active MII state of
rhodopsin (Brown, 1994; Botelho et al., 2006). Due to activation,
TM6 moves outside of the protomer which overall expands the
receptor surface (Liu et al., 2012a) and consequently increases the
hydrophobic mismatch. To compensate this effect, the receptor
has three options: association with another receptor, translation
to a different membrane domain of overall increased thickness,
or both. In a more disperse membrane environment, active MII
state rhodopsins may likely diffuse to membrane areas with more
suitable properties. Additionally, an altered membrane-protein
interface due to activation may result in a shift in protonation of
a conserved glutamic acid of TM3 in rhodopsin and a thereby
stabilized conformation (Sandoval et al., 2016).
Receptormovement to areas of increasedmembrane thickness
was observed for the human δ-opioid receptor using plasmon-
waveguide resonance (Alves et al., 2005): The receptor was
shown to be preferentially incorporated in POPC-rich domains
in the absence of any ligand, while agonist-bound proteins
tended to move into sphingomyelin-rich domains of increased
thickness (Alves et al., 2005). Possible dimerization of the
receptors in both domains was not further investigated. In
summary, the hydrophobicmismatch occurs as one of the driving
forces in the association and localization of GPCRs in membrane
nano- or microdomains.
5. SPECIFIC MEMBRANE COMPONENTS
INFLUENCE GPCR OLIGOMERIZATION
AND SIGNALING
5.1. Cholesterol
One of the most prominent membrane components which shows
enlarged concentrations in membrane rafts or nanodomains
and was frequently reported to regulate GPCR signaling is
cholesterol (Oates and Watts, 2011). In general, cholesterol is
considered to increase the membrane thickness by inducing
higher order to preferentially saturated lipid tails. Several studies
revealed cholesterol as one of the key players in GPCR function,
however it should be noted that certain GPCRs have been shown
to function as well in membranes free of cholesterol (Oates
and Watts, 2011). Furthermore, cholesterol was reported to
be important for receptor crystallization (Salom et al., 2013),
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thus indicating that cholesterol-receptor interactions might be
important for the stability of the receptor.
Using dynamic single-molecule force spectroscopy it was
shown for the β2AR that cholesterol strengthens the interactions
between structural segments and thereby stabilizes the receptor
kinetically, energetically and mechanically (Zocher et al., 2012).
The mechanism behind the stabilization was suggested as either
direct binding of cholesterol to the receptor, cholesterol-induced
facilitation of receptor oligomerization or as modulation of the
bilayer properties. Together with earlier observations that the
β2AR forms dimers in living cells (Angers et al., 2000; Salahpour
et al., 2003) and that the depletion of cholesterol increased
coupling of β2AR to Gs proteins (Pontier et al., 2008), this
functionally relevant stabilization by cholesterol may not only
act on the tertiary structure but moreover on the quaternary
structure of the receptors. Previous crystallography studies on
the β2AR revealed a cholesterol consensus motif (CCM) given as
[4.39-4.34(R,K)]−[4.50(W,Y)]−[4.46(I,V,L)]−[2.41(F,Y)] based
on the Ballesteros-Weinstein numbering scheme (Hanson et al.,
2008). Additional sequence analysis predicted that 21% of class
A GPCRs contain this CCM (Hanson et al., 2008), however
crystal structures of several of those GPCRs did not show bound
cholesterol at this site but on other parts of the receptor (Gimpl,
2016).
In case of the β2AR, two cholesterol molecules were bound to
the CCM and thereby increased the packing interactions between
TM4 and the rest of the helix bundle, yielding an overall increased
thermal stability. Additional CG MD simulations on the β2AR
were performed in order to elucidate the influence of cholesterol
on receptor dimerization and it was observed that increasing
levels of cholesterol reduce the involvement of TM4 at the dimer
interface but enhance the influence of TM1 and TM2 (Prasanna
et al., 2014). Due to binding of cholesterol to TM4 (in a similar
manner to binding to the CCM) the TM4,5/TM4,5 interface,
observed for the receptor in a pure POPC bilayer, was blocked,
while increasing levels of cholesterol (9–50%) shifted the dimer
configurations over TM1,2/TM4,5 to a symmetric TM1,2/TM1,2
interface.
Modulation of receptor function and organization was also
reported for the serotonin 5-HT1A receptor. It was observed
that the enantiomer of cholesterol (ent-cholesterol) could restore
ligand binding and receptor signaling after cholesterol-depletion,
whereas the diastereomer (epi-cholesterol) did not (Jafurulla
et al., 2014). Epi-cholesterol was shown before to have different
biophysical effects on the bilayer due to different tilt angles
and phase transition characteristics (Cheetham et al., 1989).
The ligand-independent oligomerization of serotonin 5-HT1A
receptors in living cells was observed with FRET and appeared to
be enhanced upon acute cholesterol depletion (Paila et al., 2011).
This could be due to reorganization of the receptors induced
by the change in membrane properties (e.g., larger hydrophobic
mismatch caused by the reduced membrane thickness) or by
disrupting specific cholesterol-protein interactions that possibly
occupied parts of the protein, thus impeding oligomerization at
these parts. Among different GPCRs, including the serotonin
5-HT1A receptor, another cholesterol recognition amino acid
consensus (CRAC) was identified by performing sequence
alignment studies (Jafurulla et al., 2011). The CRAC sequence
is defined as [−L/V−(X)1−5−Y−(X)1−5−R/K−] where (X)1−5
denotes between one and five unspecific amino acids, and also
the inverse CARC motif [−K/R−(X)1−5−Y−(X)1−5−L/V−]
has been identified as a possible specific cholesterol binding
site (Baier et al., 2011). With the aid of CG MD simulations,
cholesterol binding to the serotonin 5-HT1A receptor was
investigated and the highest cholesterol occupancy was obtained
for a CRAC motif on TM5 (Sengupta and Chattopadhyay,
2012). A computational model of a symmetric TM4,5/TM4,5
serotonin 5-HT1A receptor dimer was generated (Gorinski et al.,
2012) based on the obtained molecular model of rhodopsin
oligomers from atomic force microscopy maps (Fotiadis et al.,
2003). With this model, several amino acids were identified
to stabilize the dimer interface which was subsequently tested
using FRET experiments on systems containing different types of
receptors carrying mutations at the identified residues (Gorinski
et al., 2012). Interestingly, mutations of several amino acids
reduced the apparent FRET efficiency from 18.9% to about
12%, indicating that the proposed TM4,TM5/TM4,5 dimer is
indeed, among other dimer conformations, present in living cells.
Together with the aforementioned experiments which revealed
a cholesterol-mediated function and activity of the serotonin
5-HT1A receptor (Jafurulla et al., 2014), the increased FRET
signals upon cholesterol depletion (Paila et al., 2011) and the
identified cholesterol binding site on the CRAC motif located on
TM5 (Sengupta and Chattopadhyay, 2012), cholesterol appears
to regulate receptor activity by occupying the TM5 helix that
modulates the involvement of TM5 in dimer conformations.
In case of the chemokine receptor CXCR4, the depletion of
cholesterol with either hydroxy-propyl-β-cyclodextrin (Nguyen
and Taub, 2002) or methyl-β-cyclodextrin (Wang et al.,
2006) abolished CXCR4 signaling by impeding ligand
binding. Further FRET studies showed that the absence of
cholesterol or blocking the TM4 helix also reduced receptor
association (Wang et al., 2006). BRET studies showed that the
presence of TM2 and TM4 peptides (derived from TM2 and
TM4 of CXCR4) abolished agonist-induced rearrangement in
preexisting CXCR4 homodimers and further blocked receptor
signaling (Percherancier et al., 2005). TM6 and TM7 petides
did not impede conformational changes upon ligand binding,
whereas receptor signaling was still reduced (Percherancier
et al., 2005). In addition, oxidation of membrane cholesterol
to 4-cholesten-3-one catalyzed by the cholesterol oxidase also
inhibited binding of an agonist and thus led to reduced signaling
of the chemokine receptors CXCR4 and CCR5 (Nguyen and
Taub, 2003). These observations indicate the specific requirement
of membrane cholesterol for proper receptor function where
the sterol may either specifically bind to the protein or alter the
membrane properties in a specific manner. In order to shed light
on the interplay of cholesterol and CXCR4, CG MD simulations
were performed on the CXCR4 crystal structure (Wu et al., 2010)
with the goal to investigate the receptor’s cholesterol-conditioned
homodimerization (Pluhackova et al., 2016). The main findings
are that while the most frequently observed dimer interface
in pure POPC membranes, namely TM1/TM5-7, is strongly
impeded in presence of cholesterol due to specific binding of
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cholesterol to a groove between TM1 and TM7, the symmetric
TM3,4/TM3,4 interface was enabled first by intercalation of
cholesterol molecules between the protomers. In orchestra with
the previously reported experimental studies where cholesterol
depletion and TM4 blocking was shown to reduce CXCR4
signaling, the cholesterol-induced TM3,4/TM3,4 dimer appears
as an intriguing candidate for an active conformation. On
the other hand, the TM1/TM5-7 interface, highly present in
cholesterol-free membranes, might show an inactive dimer based
on the fact, that TM6 is directly involved and thereby possibly
trapped at the dimer interface (Pluhackova et al., 2016).
For the oxytocin receptor (class A GPCR) it was shown that
the presence of cholesterol increases receptor stability and the
affinity for agonist or antagonist binding (Klein et al., 1995;
Muth et al., 2011). This stabilization was further suggested as
being highly specific, given that structure-activity analyses of
several cholesterol analogs showed reduced stabilization (Gimpl
and Fahrenholz, 2002). In vivo oxytocin receptor oligomers
have been observed using BRET and it was further shown
that a treatment with oxytocin weakens the observed BRET
signals (Devost and Zingg, 2004). These observations could hint
to a mechanism where cholesterol either specifically alters the
membrane properties or binds to the oxytocin receptor and
thereby facilitates receptor oligomerization which enhances the
activity of the receptor. Ligand-binding may either modulate the
oligomeric interface or disrupt protein complexes due to induced
conformational changes in the receptor protomers.
Another prominent member of class A GPCRs is the
µ-opioid receptor which was also reported to show cholesterol-
regulated activity (Huang et al., 2007; Qiu et al., 2011). By
comparing the influence of two different membrane nanodomain
disrupting agents, namely simvastatin (reductase that blocks
cholesterol synthesis) and D-threo-1-phenyl-2-decanoylamino-
3-morpholino-1-propanol (DPDMP, inhibitor that blocks
glycosphingolipid synthesis), possible regulation mechanisms
of cholesterol in receptor function were investigated (Zheng
et al., 2012b). DPDMP disrupted membrane nanodomains
without reducing the cholesterol content but did not affect G
protein coupling to the µ-opioid receptor, whereas treatment
with simvastatin impaired receptor signaling. Therefore, it was
suggested that cholesterol is not only important to stabilize
membrane nanodomains in order to provide a platform for
protein partitioning, thus facilitating the coupling between
receptors and G proteins. Moreover, direct protein-cholesterol
interactions seem to be essential for proper signaling. Several
earlier studies suggested that the association of µ-opioid
receptors to homo- or heteromultimers with other opiod
receptors also plays a role in receptor function (Jordan and
Devi, 1999; Li-Wei et al., 2002). Recent crystal structures of
the µ-opioid receptor revealed receptor dimers and oligomers
with bound cholesterol molecules (Manglik et al., 2012; Huang
et al., 2015). The first crystal structure was obtained from
antagonist-bound receptors and actually revealed two protein-
protein interfaces formed by TM1,TM2,H8/TM1,TM2,H8
or TM5,6/TM5,6 interactions (Manglik et al., 2012) (see
Figure 4A). The latter interface appears to be stabilized by
cholesterol molecules located at the N-terminal groove between
TM6 and TM7 reaching toward TM5 of the associated receptor.
Interestingly, the second crystal structure shows the µ-opioid
receptor bound to an agonist and coupled to a G protein mimetic
camelid antibody fragment, thus resembling a ligand-activated
GPCR configuration (Huang et al., 2015) (see Figure 4A). As
reported for the former structure, one cholesterol molecule
is bound to the groove between TM6 and TM7 and one of
the dimeric interfaces is mainly constructed by symmetric
interactions involving TM1, TM2 and H8. On the other
hand, due to the activation-related outwards movement of the
intracellular part of TM6, the compact TM5,6/TM5,6 dimer, as
it was observed for inactive receptors, could not be formed by
active receptors (see Figure 4B).
These findings again illustrate, that dimer conformations of
GPCRs differ between active and inactive forms and additionally
allow to speculate that specific cholesterol intercalation may
contribute to the regulation of GPCR activation. This regulation
may be especially important in case of receptors that activate
constitutively. Constitutive activation was proposed for several
GPCRs if the “ionic lock”-salt bridge between an arginine, located
in the conserved intracellular DRYmotif on TM3, and negatively
charged residues on TM6 is missing (Schneider et al., 2010).
5.1.1. Cholesterol Intercalation in GPCR Crystal
Structures
In regard to the continuously growing number of available GPCR
crystal structures, the requirement of cholesterol during the
crystallization trial is reported with increasing regularity (Salom
et al., 2013; Gimpl, 2016). Some of these GPCR structures
were actually solved as receptor dimers or oligomers and
showed cholesterol intercalation between protomers. The crystal
structure of the A2A adenosine receptor showed an asymmetric
TM1-TM3/TM5,6 interface (Liu et al., 2012b) (see Figure 5A). In
total three cholesterol and 14 single chain lipid molecules, mainly
from the extracellular leaflet, are present between the protomers.
One cholesterol molecule is bound to a groove between TM2 and
TM3, which is further stabilized by a hydrogen bond between
cholesterol and the extracellular loop between these helices.
The other two sterols are closely packed to TM6 reaching into
grooves between either TM5 and TM6 or TM6 and TM7. The
crystal packing additionally shows a symmetric TM4,5/TM4,5
dimer interface without any intercalating cholesterol molecules,
however a small number of lipids reaching into the interprotein
clefts. The interplay between the A2A adenosine receptor and
cholesterol was analyzed earlier with biochemical techniques and
revealed the requirement of cholesterol for proper G protein
coupling (Zezula and Freissmuth, 2008). Further computational
studies suggested that binding of cholesterol molecules to TM2
markedly stabilized the receptor conformation (Lyman et al.,
2009).
The above discussed P2Y12 receptor was recently investigated
via protein crystallography. The resolved dimer structure
involved TM5 and TM6 contacts (Zhang et al., 2014). This
dimer interface is further stabilized by bound cholesterol from
the lower intracellular leaflet between TM3 and TM5 of each
receptor (see Figure 5B). Another cholesterol molecule from the
extracellular leaflet was found to bind between TM1 and TM7,
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FIGURE 4 | µ-opioid (µOR) crystal structures. Color Code: TM1: red, TM2: light blue, TM3: yellow, TM4: brown, TM5: purple, TM6: dark blue, TM7: green, H8:
orange, cholesterol: teal. (A) µORs dimer interfaces in crystal structures are shown from the extracellular site: inactive protomers (PDB: 4DKL, Manglik et al., 2012,
left) and active receptors (PDB: 5C1M, Huang et al., 2015, right). A structure alignment between the inactive (bright colors) and the active (dark colors) form is shown
above the transition arrow. (B) Inactive µOR form a symmetric TM5,6/TM5,6 interface that is stabilized by cholesterol (left), while a structure alignment of active µORs
onto this dimer interface revealed steric clashes at the intracellular parts of TM5 and TM6 (highlighted in red).
thus not contributing to the association interface. In addition,
a symmetric TM4,5/TM4,5 interface could be resolved without
bound sterols. The related receptor P2Y1 was as well crystallized
with one cholesterol bound to the extracellular groove between
TM4 and TM5 (Zhang et al., 2015). The crystal packing reveals a
multimeric superstructure where one TM4,5-bound cholesterol
is in close contact to TM7 of one neighboring receptor and
close to TM1 and TM2 of another neighbor (see Figure 5C). In
addition to the cholesterol molecules, several lipids fill up gaps
between the protomers.
As already mentioned, oligomerization is overall accepted to
be essential for class C GPCR function (Kniazeff et al., 2011).
The most famous member of this subfamily is the metabotropic
glutamate receptor mGluR whose transmembrane domain was
recently resolved (Wu et al., 2014). Here, six cholesterol
molecules are intercalated between the receptor protomers with
close contacts to extracellular, mainly hydrophobic residues of
TM1, TM2, and TM3 (see Figure 5D).
In summary, cholesterol appears as a key player in regulating
GPCR function. Cholesterol has the ability to adjust membrane
properties and to directly interact with receptor monomers and
oligomers. Especially direct interactions between GPCRs and
cholesterol are proposed to offer complex regulationmechanisms
of receptor function: Cholesterol-binding to specific parts of
the receptor surface promotes distinct configurations either by
occupying parts of the protein, thus disabling certain areas from
contributing to a dimer interface, or by intercalating between
protomers in order to stabilize certain quaternary structures.
5.2. Polyunsaturated Fatty Acid Chains
Another membrane component reported to be involved
in GPCR regulation is the polyunsaturated omega-3 fatty
acid docosahexaenoic (DHA, 22:6n-3). Membranes with
increased concentrations of DHA show low lipid order (Mitchell
and Litman, 1998). This low order can be reasoned by
the high conformational flexibility of DHA chains due to
their large number of unsaturated hydrocarbons which
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FIGURE 5 | GPCR crystal structures show cholesterol intercalation between protomers. Crystal structures and packing of four different GPCRs. Color Code:
TM1: red, TM2: light blue, TM3: yellow, TM4: brown, TM5: purple, TM6: dark blue, TM7: green, H8: orange, cholesterol: teal. Detailed cholesterol binding sites are
depicted in a combination of surface, colored according to charge (red: negative, blue: positive) and cartoon representation. (A) A2A adenosine receptor dimers (PDB:
4EIY, Liu et al., 2012b) are shown from the extracellular site and in a site view, additional lipids are shown in light orange. (B) P2Y12 receptor dimer (PDB: 4NTJ,
Zhang et al., 2014) in a site view, (C) P2Y1 receptor heptamer (PDB: 4XNV, Zhang et al., 2015) from the extracellular site, (D) Metabotrobic glutamate receptor dimer
(PDB: 4OR2, Wu et al., 2014) from the extracellular site and in a site view.
allow for conformational adaptations of the membrane
without significant energetic penalty (Gawrisch et al., 2008).
Reconstitution of rhodopsin into membranes with high DHA
levels revealed that the presence of DHA in close vicinity
of the receptor accelerates the formation of the active MII
state and coupling to transducin (Niu et al., 2004). In turn,
Mitchell et al. reported an inhibitory effect of increased levels of
cholesterol and phospholipid acyl chain saturation on rhodopsin
function (Mitchell et al., 2003). In addition to internal free
energy changes, it was proposed that the differences in shape
between the inactive MI and the MII conformation imply
different free energy contributions arising from the work against
the lateral pressure from the surrounding lipids (Gawrisch et al.,
2008). Membranes containing more polyunsaturated fatty acids
typically exhibit a decreased thickness (for equally long fatty acid
chains) and an increased area per lipid. This structural change as
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well as the difference in order will be accompanied by changes in
the lateral pressure profile of the membrane and thus modulate
the equilibrium between different receptor states that differ in
their cross-sectional area.
Apart from DHA-related differences in the lateral pressure
acting on the receptor, an altered membrane curvature was
suggested to modulate the GPCR function (Escribá et al.,
2007). The lipid composition of the retinal rod outer segment
membrane, where rhodopsin is naturally abundant, contains up
to 50% of DHA lipids and it was shown that these lipids tend
to induce a negative spontaneous curvature, thus facilitating the
elongation of the receptor upon activation (Feller and Gawrisch,
2005).
Another hypothesis concerning the preferred solvation of
rhodopsin in DHA-rich membranes was contributed from a
computational study. It was suggested that the entropic penalty
for lipid-protein contacts is significantly smaller for unsaturated
chains as compared to saturated hydrocarbon tails (Grossfield
et al., 2006b). The reduction of entropic penalty can be reasoned
by the increased flexibility and energetic degeneracy of DHA
chains as compared to saturated lipids. Even tightly bound
DHA chains at the protein surface were reported to reorient at
similar rates as lipids distal of the protein (Feller et al., 2003;
Grossfield et al., 2006b). Also direct binding of DHA chains to the
receptor surface was reported for rhodopsin. It was suggested that
especially pi-pi interactions between the acyl chain double bonds
and the aromatic side chains of the receptor surface stabilize the
protein-lipid interactions (Gawrisch et al., 2008).
Additionally, due to their high flexibility, DHA chains can
easily penetrate or adopt to the structured surface of the TM
portion of the receptor with lower energy costs as compared to
saturated side chains (Feller et al., 2003). Using MD simulations,
it was shown that DHA associates to a small number of distinct
regions on rhodopsin (mainly grooves between helices) and that
binding of DHA weakens local helix-helix interactions which
may facilitate the transition to the MII state (Grossfield et al.,
2006a).
A recent study analyzed the effect of DHA chains on receptor
oligomerization with a combination of multiscale computer
modeling and BRET experiments (Guixà-González et al., 2016).
It was shown that DHA improves the oligomerization kinetics
of adenosine A2A and dopamine D2 receptors. In coarse-grained
simulations, it was observed that DHA-rich lipids cluster around
both receptors and that high levels of DHA enhance protein
heteromerization. However, the amount of oligomers was not
increased by DHA lipids in the BRET experiments. Therefore,
the authors concluded a purely kinetic modulation of the
oligomerization. Possible explanations for these observations are
increased lateral diffusion rates in DHA-rich membranes and
a possible lipid phase segregation into DHA-rich and DHA-
poor domains. It was suggested that the redistribution of other
membrane components aroundDHA leads to partioning of DHA
into DHA-rich domains (Pitman et al., 2005).
The aggregation of proteins may thus be accelerated due
to membrane-driven colocalization of DHA-coated proteins,
hence the oligomerization kinetics of DHA-coated proteins
do not purely depend on protein-protein interactions alone.
Moreover, additional attraction between DHA chains improves
the aggregation kinetics (Guixà-González et al., 2016).
6. PALMITOYLATION OF GPCRS
Besides interactions between proteins and membrane
components, lipids can also be covalently bound to GPCRs.
Due to a post-translational modification called palmitoylation,
the saturated fatty acid palmitic acid (16 carbons) is usually
added to carboxyl-terminal cysteine residues via a thioester-type
bond (Chini and Parenti, 2009). It was reported that GPCRs
can be mono-, bis- or even tris-palmitoylated and that this
lipid modification is reversible as well as adjustable, allowing
thereby regulation of GPCR function (Qanbar and Bouvier,
2003). However, this modulation of GPCR function by means
of palmitoylation is not a common feature of all GPCRs, given
that palmitoylation was reported to be either independent
or dependent on ligand binding (Chini and Parenti, 2009),
and also the effect on GPCR function was reported as either
significant (Blanpain et al., 2001) or only small (Ponimaskin
et al., 2002).
The serotonin 5-HT1A receptor was shown to be naturally
acylated at the two conserved cysteine residues 417 and
420 (Papoucheva et al., 2004). The palmitoylation was found
to be independent of agonist stimulation and further to occur
early after receptor synthesis. Prevention of the post-translational
modifications by mutating the carboxyl-terminal cysteines,
weakened or even abolished coupling between receptors and
G proteins, thus reducing the native inhibition of forskolin-
promoted cAMP formation upon agonist stimulation. These
findings suggest that acylation stabilizes a specific conformation
of the carboxyl-terminal part to facilitate G protein coupling, or
that the attached palmitic acids regulate the receptors trafficking
and localization into membrane nanodomains, which was
discussed before as important for proper signaling (Papoucheva
et al., 2004). Fluorescence and gradient centrifugation studies
on the serotonin 5-HT1A receptor indeed revealed that
native palmitoylated receptors localize mainly in membrane
nanodomains, whereas palmitoylation-deficient mutants are
considerably less abundant in these raft domains (Renner
et al., 2007). The disruption of nanodomains by using methyl-
β-cyclodextrin led to reduced localization of wild type 5-
HT1A receptors and G protein subunits (Renner et al., 2007).
Therefore, the palmitoylation-driven colocalization of 5-HT1A
receptors is considered important for regulating the signaling
process (Renner et al., 2007).
Using advanced FRET techniques, the effect of plalmitoylation
on 5-HT1A receptor oligomers was investigated (Kobe et al.,
2008). Wild type acylated receptors showed significantly
decreased FRET efficiencies upon agonist stimulation, however
co-immunoprecipitation and cross-linking studies revealed a
similar amount of oligomers. Consequently, agonist-binding was
suggested to induce changes in the oligomeric conformation
(into a FRET-negative conformation) rather than dissociation
of monomers from protein complexes. In contrast, the FRET
efficiency was increased in cells expressing non-acylated receptor
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mutants and the agonist-induced decrease of FRET efficiency
was completely abolished (Kobe et al., 2008). Additionally,
cholesterol depletion significantly increased the FRET signal
only for wild type receptors, indicating the conversion back
into the FRET-positive conformation. These findings for the
5-HT1A receptor hint to a mechanism where palmitoylation
caters for the compartmentalization of receptors and of
receptor oligomers in membrane nanodomains. It further
allows for agonist-induced changes of oligomeric conformation
either by direct interactions between the palmitic acids and
specific membrane components, or by facilitating coupling
to G proteins (which are also more abundant in membrane
nanodomains). Receptor oligomers located outside of these
membrane areas may partly be non-functional but could be
“turned on” by palmitoylation-mediated trafficking into the
corresponding membrane nanodomains (Kobe et al., 2008). The
structure of the related serotonin 5-HT2B receptor was recently
solved using X-ray crystallography and showed a palmitoylated
cysteine (Cys397) on H8 (Wacker et al., 2013). Furthermore,
one cholesterol molecule was located in the valley formed
between TM1 and H8 with two monoolein molecules in close
vicinity.
A crystal structure of a β2AR dimer was solved including a
palmitoylated cysteine residue on the H8 helix (Cys341) at the
dimer interface (Cherezov et al., 2007) (see Figure 6). In addition
to the palmitic acids, six cholesterol molecules are involved in
the symmertic TM1,H8/TM1,H8 dimer interface. Two of these
cholesterol molecules appear to be stabilized by interactions with
the palmitic acids. Overall, more than 70% of the total buried
surface area (515 Å2) at the interface is mediated by lipids, and
direct protein-protein interactions are only observed between the
charged lysine at position 60 on TM1 and the glutamic acid at
position 338 on H8.
This dimer structure as well as previous studies on the
importance of membrane cholesterol for β2AR-related signaling
suggest the possibility of a specific modulation of β2AR function
by membrane components. While the β2AR couples to Gs and Gi
proteins with similar rates in living cells, depletion of cholesterol
revealed an increased coupling to Gs proteins (Xiang et al.,
2002). Additionally, Gs protein coupling was reported to occur to
receptor monomers (Whorton et al., 2007). The palmitoylation-
mediated cholesterol recruitment possibly facilitates receptor
dimerization and thus may shift the coupling preference over to
Gi proteins due to the formation of a specific quaternary structure
of the β2AR.
The influence of interactions between covalently attached
palmitic acids and cholesterol on dimerization were also
addressed for the µ-opioid receptor (Zheng et al., 2012a).
In constrast to typical palmitoylation sites at the carboxyl-
terminus, cysteine 170 on TM3 was identified as the acylation site
using immunoblotting techniques. Performing colocalization,
co-immunoprecipitation and FRET analyses revealed that wild
type receptors oligomerize more efficiently as compared to
populations consisting of wild type receptors and mutants
(C170A) or exclusively mutated receptors. Additionally, a
positive correlation between G protein coupling and receptor
palmitoylation was observed suggesting that reduced receptor
dimerization decreased G protein coupling. Cholesterol was
found to be more frequently associated with receptor complexes
formed by wild type receptors hinting to the recruitment of
cholesterol by palmitic acid. The importance of associated
cholesterol was further analyzed using FRET methods and it
FIGURE 6 | Palmitoylated β2AR dimer (PDB: 2RH1 Cherezov et al., 2007). Color Code: TM1: red, TM2: light blue, TM3: yellow, TM4: brown, TM5: purple, TM6:
dark blue, TM7: green, H8: orange, cholesterol: teal, palmitic acid: light orange. The sulfur group of the palmitoylated Cys341 is shown as a yellow sphere. The
surface of the receptor (right) is colored according to the charge of the receptor (inset, red: negative, blue: positive).
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was reported that the absence of cholesterol decreased wild type
receptor oligomerization and further G protein coupling. To
validate these results the influence of a palmitoylation inhibitor
(2-BP) was tested. It was indeed observed that upon 2-BP
treatment both, homodimerization and cholesterol association
were reduced to a similar level as for systems expressing the
C170A mutants. In addition, a computational homology model
based on a crystal structure of the β2AR (Rasmussen et al., 2007)
was produced for the µ-opioid receptor to further analyze the
suggested the homodimer. Based on Conformational Memories
calculations, TM4 was indicated to mainly build up the dimer
interface and the palmitic acid attached to TM3 facilitates
packing of a cholesterol molecule between TM3 and TM4 of each
protomer.
Consequently, similar to the previously discussed β2AR
dimer, two palmitoylation-recruited cholesterol molecules are
directly involved in stabilizing the dimer interface. However,
an interesting difference arises from comparing palmitoylation
sites and dimeric interfaces between the two described receptors:
The β2AR appeared to be palmitoylated at the carboxyl-terminal
cysteine on H8 which is involved in building up a symmetric
TM1,H8/TM1,H8 dimer interface with intercalated cholesterol.
In case of the µ-opioid receptor, TM3 carries the palmitoylation
site which further mediates cholesterol association to stabilize
a symmetric TM3,4/TM3,4 interface. In summary one may
speculate that palmitoylation is regulating GPCR function due
to the recruitment of cholesterol in order to stabilize a specific
dimer interface (Goddard and Watts, 2012b).
7. CONCLUSIONS
In summary, both the experimental and computational
evidence for a significant influence of the lipid environment
on GPCR function and organization is overwhelming.
Compartmentalization of GPCRs in membrane nanodomains
(caveolar and non-caveolar) appears to be essential for numerous
GPCR-mediated signaling events. The reasons for this necessity
seem to be spread over different factors: Colocalization of
GPCRs with other signaling components (mainly G proteins), a
decreased hydrophobic mismatch and close vicinity to specific
lipids and cholesterol. Especially cholesterol plays a key role in
GPCR trafficking, organization and function. Several studies
hinted to conformational changes in preexisting dimers and
oligomers upon cholesterol depletion (Devost and Zingg,
2004; Paila et al., 2011; Pluhackova et al., 2016). In addition,
protein-cholesterol interactions have been reported as essential
for efficient GPCR signaling (Nguyen and Taub, 2002, 2003;
Zheng et al., 2012b; Jafurulla et al., 2014). Likely, the GPCR
dimer equilibrium between both, active and inactive dimers is
shifted by the addition/depletion of cholesterol to active/inactive
dimers.
Function-competent oligomers are suggested to be stabilized
via interactions between their transmembrane helices excluding
TM6 (Zheng et al., 2012a; Huang et al., 2015; Pluhackova et al.,
2016). In order to regulate the crucial receptor-cholesterol
interactions, palmitoylation is revealed to recruit cholesterol
to dimeric interfaces thus stabilizing specific quaternary
structures (Cherezov et al., 2007; Chini and Parenti, 2009; Zheng
et al., 2012a). The influence of specific membrane components
can be further analyzed by performing a reconstitution of GPCRs
to artifical membrane systems (e.g., GUVs) with controlled
properties. Both, protein crystallography or computer-based
studies are ideally suited to guide future studies on receptor-
receptor and receptor-lipid interactions. Advances in both,
experiment and simulation, are expected also to solve the
seeming discrepancy between the reported localization of
GPCRs in densely packed, probably ordered lipid nano- or
microdomains and their association to polyunsaturated and thus
disordered lipids.
Besides, GPCR hetero-oligomerization gains increasing
interest, since a large number of GPCRs revealed
binding cooperativity and heterodimerization-dependent
trafficking (Prinster et al., 2005). However, far less structural
information is available for hetero-oligomeric complexes as
compared to homo-oligomers. In order to further investigate
the complex interaction network between GPCRs it is of great
importance to determine whether heteromers show a similar
lipid-dependent function and organization as homomers. All in
all, this review stresses the necessity to carefully include the effect
of the lipid nanodomain environment in any study on GPCR
structure and function.
AUTHOR CONTRIBUTIONS
SG and RB developed the concept of this review and wrote the
manuscript.
FUNDING
This work was funded by the DFG Research Training Group
1962/1, “Dynamic Interactions at Biological Membranes: From
Single Molecules to Tissue.”
REFERENCES
Alemany, R., Perona, J. S., Sánchez-Dominguez, J. M., Montero, E., Cañizares, J.,
Bressani, R., et al. (2007). G protein-coupled receptor systems and their lipid
environment in health disorders during aging. Biochim. Biophys. Acta 1768,
964–975. doi: 10.1016/j.bbamem.2006.09.024
Alves, I. D., Salamon, Z., Hruby, V. J., and Tollin, G. (2005). Ligand modulation of
lateral segregation of a G-protein-coupled receptor into lipid microdomains in
sphingomyelin/phosphatidylcholine solid-supported bilayers. Biochemistry 44,
9168–9178. doi: 10.1021/bi050207a
Angers, S., Salahpour, A., and Bouvier, M. (2002). Dimerization:
an emerging concept for G protein-coupled receptor ontogeny
and function. Annu. Rev. Pharmacol. Toxicol. 42, 409–435. doi:
10.1146/annurev.pharmtox.42.091701.082314
Angers, S., Salahpour, A., Joly, E., Hilairet, S., Chelsky, D., Dennis, M., et al.
(2000). Detection of β2-adrenergic receptor dimerization in living cells using
Frontiers in Physiology | www.frontiersin.org 13 October 2016 | Volume 7 | Article 494
Gahbauer and Böckmann Membrane-Mediated GPCR Oligomerization
bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci.
U.S.A. 97, 3684–3689. doi: 10.1073/pnas.060590697
Ayoub, M. A., and Pfleger, K. D. (2010). Recent advances in bioluminescence
resonance energy transfer technologies to study GPCR heteromerization. Curr.
Opin. Pharm. 10, 44–52. doi: 10.1016/j.coph.2009.09.012
Baier, C. J., Fantini, J., and Barrantes, F. J. (2011). Disclosure of cholesterol
recognition motifs in transmembrane domains of the human nicotinic
acetylcholine receptor. Sci. Rep. 1:69. doi: 10.1038/srep00069
Bayburt, T. H., Leitz, A. J., Xie, G., Oprian, D. D., and Sligar, S. G. (2007).
Transducin activation by nanoscale lipid bilayers containing one and two
rhodopsins. J. Biol. Chem. 282, 14875–14881. doi: 10.1074/jbc.M701433200
Bhatnagar, A., Sheﬄer, D. J., Kroeze, W. K., Compton-Toth, B., and Roth, B. L.
(2004). Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly
modulates the signaling of selected Gαq-coupled protein receptors. J. Biol.
Chem. 279, 34614–34623. doi: 10.1074/jbc.M404673200
Blanpain, C., Wittamer, V., Vanderwinden, J. M., Boom, A., Renneboog, B., Lee,
B., et al. (2001). Palmitoylation of CCR5 is critical for receptor trafficking
and efficient activation of intracellular signaling pathways. J. Biol. Chem. 276,
23795–23804. doi: 10.1074/jbc.M100583200
Botelho, A. V., Huber, T., Sakmar, T. P., and Brown, M. F. (2006). Curvature and
hydrophobic forces drive oligomerization and modulate activity of rhodopsin
in membranes. Biophys. J. 91, 4464–4477. doi: 10.1529/biophysj.106.082776
Broussard, J. A., Rappaz, B., Webb, D. J., and Brown, C. M. (2013). Fluorescence
resonance energy transfer microscopy as demonstrated by measuring the
activation of the serine/threonine kinase Akt. Nat. Protoc. 8, 265–281. doi:
10.1038/nprot.2012.147
Brown, M. F. (1994). Modulation of rhodopsin function by properties of
the membrane bilayer. Chem. Phys. Lipids 73, 159–180. doi: 10.1016/0009-
3084(94)90180-5
Calebiro, D., Rieken, F., Wagner, J., Sungkaworn, T., Zabel, U., Borzi, A., et al.
(2013). Single-molecule analysis of fluorescently labeled G-protein-coupled
receptors reveals complexes with distinct dynamics and organization. Proc.
Natl. Acad. Sci. U.S.A. 110, 743–748. doi: 10.1073/pnas.1205798110
Chavent, M., Chetwynd, A. P., Stansfeld, P. J., and Sansom, M. S. (2014).
Dimerization of the EphA1 receptor tyrosine kinase transmembrane domain:
insights into themechanism of receptor activation. Biochemistry 53, 6641–6652.
doi: 10.1021/bi500800x
Cheetham, J. J., Wachtel, E., Bach, D., and Epand, R. M. (1989). Role of the
stereochemistry of the hydroxyl group of cholesterol and the formation of
nonbilayer structures in phosphatidylethanolamines. Biochemistry 28, 8928–
8934. doi: 10.1021/bi00448a036
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G., Thian, F. S.,
Kobilka, T. S., et al. (2007). High-resolution crystal structure of an engineered
human β2-adrenergic G protein-coupled receptor. Science 318, 1258–1265. doi:
10.1126/science.1150577
Chini, B., and Parenti, M. (2009). G-protein-coupled receptors, cholesterol
and palmitoylation: facts about fats. J. Mol. Endocrinol. 42, 371–379. doi:
10.1677/JME-08-0114
Cordomí, A., Navarro, G., Aymerich, M. S., and Franco, R. (2015). Structures
for G-protein-coupled receptor tetramers in complex with G proteins. Trends
Biochem. Sci. 40, 548–551. doi: 10.1016/j.tibs.2015.07.007
Cottet, M., Faklaris, O., Maurel, D., Scholler, P., Doumazane, E., Trinquet, E., et al.
(2012). BRET and time-resolved FRET strategy to studyGPCR oligomerization:
from cell lines toward native tissues. Front. Endocrinol. (Lausanne) 3:92. doi:
10.3389/fendo.2012.00092
de Jong, D. H., Singh, G., Bennett, W. D., Arnarez, C., Wassenaar, T. A., Schafer,
L. V., et al. (2012). Improved parameters for the Martini coarse-grained protein
force field. J. Chem. Theory Comput. 9, 687–697. doi: 10.1021/ct300646g
de Meyer, F., and Smit, B. (2009). Effect of cholesterol on the structure of
a phospholipid bilayer. Proc. Natl. Acad. Sci. U.S.A. 106, 3654–3658. doi:
10.1073/pnas.0809959106
Devost, D., and Zingg, H. H. (2004). Homo- and hetero-dimeric complex
formations of the human oxytocin receptor. J. Neuroendocrinol. 16, 372–377.
doi: 10.1111/j.0953-8194.2004.01188.x
Escribá, P. V., Wedegaertner, P. B., Goñi, F. M., and Vögler, O. (2007). Lipid–
protein interactions in GPCR-associated signaling. Biochim. Biophys. Acta
1768, 836–852. doi: 10.1016/j.bbamem.2006.09.001
Fallahi-Sichani, M., and Linderman, J. J. (2009). Lipid raft-mediated regulation
of G-protein coupled receptor signaling by ligands which influence
receptor dimerization: a computational study. PLoS ONE 4:e6604. doi:
10.1371/journal.pone.0006604
Feller, S. E., and Gawrisch, K. (2005). Properties of docosahexaenoic-acid-
containing lipids and their influence on the function of rhodopsin. Curr. Opin.
Struct. Biol. 15, 416–422. doi: 10.1016/j.sbi.2005.07.002
Feller, S. E., Gawrisch, K., andWoolf, T. B. (2003). Rhodopsin exhibits a preference
for solvation by polyunsaturated docosohexaenoic acid. J. Am. Chem. Soc. 125,
4434–4435. doi: 10.1021/ja0345874
Förster, T. (1948). Zwischenmolekulare Energiewanderung und Fluoreszenz.
Annalen Physik 437, 55–75. doi: 10.1002/andp.19484370105
Fotiadis, D., Liang, Y., Filipek, S., Saperstein, D. A., Engel, A., and Palczewski, K.
(2003). Atomic-force microscopy: rhodopsin dimers in native disc membranes.
Nature 421, 127–128. doi: 10.1038/421127a
Gawrisch, K., Soubias, O., and Mihailescu, M. (2008). Insights from biophysical
studies on the role of polyunsaturated fatty acids for function of G-protein
coupled membrane receptors. Prostaglandins Leukot. Essent. Fatty Acids 79,
131–134. doi: 10.1016/j.plefa.2008.09.002
Ghosh, E., Kumari, P., Jaiman, D., and Shukla, A. K. (2015). Methodological
advances: the unsung heroes of the GPCR structural revolution. Nat. Rev. Mol.
Cell Biol. 16, 69–81. doi: 10.1038/nrm3933
Gimpl, G. (2016). Interaction of G protein coupled receptors and cholesterol.
Chem. Phys. Lipids 199, 61–73. doi: 10.1016/j.chemphyslip.2016.04.006
Gimpl, G., and Fahrenholz, F. (2002). Cholesterol as stabilizer of the
oxytocin receptor. Biochim. Biophys. Acta 1564, 384–392. doi: 10.1016/S0005-
2736(02)00475-3
Goddard, A. D., Dijkman, P. M., Adamson, R. J., and Watts, A. (2013).
Lipid-dependent GPCR dimerization. Methods Cell Biol. 117, 341–357. doi:
10.1016/B978-0-12-408143-7.00018-9
Goddard, A. D., and Watts, A. (2012a). Contributions of fluorescence techniques
to understanding G protein-coupled receptor dimerisation. Biophys. Rev. 4,
291–298. doi: 10.1007/s12551-012-0073-z
Goddard, A. D., andWatts, A. (2012b). Regulation of G protein-coupled receptors
by palmitoylation and cholesterol. BMC Biol. 10:27. doi: 10.1186/1741-
7007-10-27
Gorinski, N., Kowalsman, N., Renner, U., Wirth, A., Reinartz, M. T., Seifert, R.,
et al. (2012). Computational and experimental analysis of the transmembrane
domain 4/5 dimerization interface of the serotonin 5-HT(1A) receptor. Mol.
Pharmacol. 82, 448–463. doi: 10.1124/mol.112.079137
Griffin, B. A., Adams, S. R., and Tsien, R. Y. (1998). Specific covalent labeling
of recombinant protein molecules inside live cells. Science 281, 269–272. doi:
10.1126/science.281.5374.269
Grossfield, A., Feller, S. E., and Pitman, M. C. (2006a). A role for direct interactions
in the modulation of rhodopsin by omega-3 polyunsaturated lipids. Proc. Natl.
Acad. Sci. U.S.A. 103, 4888–4893. doi: 10.1073/pnas.0508352103
Grossfield, A., Feller, S. E., and Pitman, M. C. (2006b). Contribution of omega-
3 fatty acids to the thermodynamics of membrane protein solvation. J. Phys.
Chem. B 110, 8907–8909. doi: 10.1021/jp060405r
Guixà-González, R., Javanainen, M., Gomez-Soler, M., Cordobilla, B., Domingo,
J. C., Sanz, F., et al. (2016). Membrane omega-3 fatty acids modulate the
oligomerisation kinetics of adenosine A2A and dopamine D2 receptors. Sci. Rep.
6:19839. doi: 10.1038/srep19839
Guo, W., Shi, L., Filizola, M., Weinstein, H., and Javitch, J. A. (2005). Crosstalk
in G protein-coupled receptors: changes at the transmembrane homodimer
interface determine activation. Proc. Natl. Acad. Sci. U.S.A. 102, 17495–17500.
doi: 10.1073/pnas.0508950102
Han, J., Pluhackova, K., Wassenaar, T. A., and Böckmann, R. A. (2015).
Synaptobrevin transmembrane domain dimerization studied by
multiscale molecular dynamics simulations. Biophys. J. 109, 760–771. doi:
10.1016/j.bpj.2015.06.049
Hanson, M. A., Cherezov, V., Griffith, M. T., Roth, C. B., Jaakola, V. P., Chien,
E. Y., et al. (2008). A specific cholesterol binding site is established by the 2.8
Å structure of the human β2-adrenergic receptor. Structure 16, 897–905. doi:
10.1016/j.str.2008.05.001
Head, B. P., Patel, H. H., Roth, D. M., Lai, N. C., Niesman, I. R.,
Farquhar, M. G., et al. (2005). G-protein-coupled receptor signaling
Frontiers in Physiology | www.frontiersin.org 14 October 2016 | Volume 7 | Article 494
Gahbauer and Böckmann Membrane-Mediated GPCR Oligomerization
components localize in both sarcolemmal and intracellular caveolin-3-
associated microdomains in adult cardiac myocytes. J. Biol. Chem. 280, 31036–
31044. doi: 10.1074/jbc.M502540200
Hipser, C., Bushlin, I., Gupta, A., Gomes, I., and Devi, L. A. (2010). Role of
antibodies in developing drugs that target G-protein-coupled receptor dimers.
Mt. Sinai J. Med. 77, 374–380. doi: 10.1002/msj.20199
Huang, P., Xu, W., Yoon, S.-I., Chen, C., Chong, P. L.-G., Unterwald, E. M., et al.
(2007). Agonist treatment did not affect association of mu opioid receptors
with lipid rafts and cholesterol reduction had opposite effects on the receptor-
mediated signaling in rat brain and CHO cells. Brain Res. 1184, 46–56. doi:
10.1016/j.brainres.2007.09.096
Huang, W., Manglik, A., Venkatakrishnan, A. J., Laeremans, T., Feinberg, E. N.,
Sanborn, A. L., et al. (2015). Structural insights into µ-opioid receptor
activation. Nature 524, 315–321. doi: 10.1038/nature14886
Ianoul, A., Grant, D. D., Rouleau, Y., Bani-Yaghoub, M., Johnston, L. J., and
Pezacki, J. P. (2005). Imaging nanometer domains of β-adrenergic receptor
complexes on the surface of cardiac myocytes.Nat. Chem. Biol. 1, 196–202. doi:
10.1038/nchembio726
Insel, P. A., Head, B. P., Patel, H. H., Roth, D. M., Bundey, R. A., and Swaney,
J. S. (2005). Compartmentation of G-protein-coupled receptors and their
signalling components in lipid rafts and caveolae. Biochem. Soc. Trans. 33(Pt
5):1131–1134. doi: 10.1042/BST0331131
Ishizaka, N., Griendling, K. K., Lassègue, B., and Alexander, R. W.
(1998). Angiotensin II type 1 receptor: relationship with caveolae and
caveolin after initial agonist stimulation. Hypertension 32, 459–466. doi:
10.1161/01.HYP.32.3.459
Jafurulla, M., Rao, B. D., Sreedevi, S., Ruysschaert, J. M., Covey, D. F., and
Chattopadhyay, A. (2014). Stereospecific requirement of cholesterol in the
function of the serotonin1A receptor. Biochim. Biophys. Acta 1838(1 Pt B):158–
163. doi: 10.1016/j.bbamem.2013.08.015
Jafurulla, M., Tiwari, S., and Chattopadhyay, A. (2011). Identification of
cholesterol recognition amino acid consensus (CRAC) motif in G-protein
coupled receptors. Biochem. Biophys. Res. Commun. 404, 569–573. doi:
10.1016/j.bbrc.2010.12.031
Jastrzebska, B., Chen, Y., Orban, T., Jin, H., Hofmann, L., and Palczewski,
K. (2015). Disruption of rhodopsin dimerization with synthetic peptides
targeting an interaction interface. J. Biol. Chem. 290, 25728–25744. doi:
10.1074/jbc.M115.662684
Jordan, B. A., and Devi, L. A. (1999). G-protein-coupled receptor
heterodimerization modulates receptor function. Nature 399, 697–700.
doi: 10.1038/21441
Kaczor, A. A., Guixàa˘-González, R., Carrió, P., Poso, A., Dove, S., Pastor, M., et al.
(2015).Multi-component protein-protein docking based protocol with external
scoring for modeling dimers of G protein-coupled receptors. Mol. Inform. 34,
246–255. doi: 10.1002/minf.201400088
Kasai, R. S., and Kusumi, A. (2014). Single-molecule imaging revealed
dynamic GPCR dimerization. Curr. Opin. Cell Biol. 27, 78–86. doi:
10.1016/j.ceb.2013.11.008
Katritsch, V., Cherezov, V., and Stevens, R. C. (2012). Diversity and modularity of
G protein-coupled receptor structures. Trends Pharmacol. Sci. 33, 17–27. doi:
10.1016/j.tips.2011.09.003
Killian, J. (1998). Hydrophobic mismatch between proteins and lipids in
membranes. BBA Rev. Biomembr. 1376, 401–416. doi: 10.1016/s0304-
4157(98)00017-3
Kimata, N., Reeves, P. J., and Smith, S. O. (2015). Uncovering the triggers for GPCR
activation using solid-state NMR spectroscopy. J. Magn. Reson. 253, 111–118.
doi: 10.1016/j.jmr.2014.12.014
Klein, U., Gimpl, G., and Fahrenholz, F. (1995). Alteration of the myometrial
plasma membrane cholesterol content with beta-cyclodextrin modulates the
binding affinity of the oxytocin receptor. Biochemistry 34, 13784–13793. doi:
10.1021/bi00042a009
Kniazeff, J., Prezeau, L., Rondard, P., Pin, J. P., and Goudet, C. (2011). Dimers and
beyond: the functional puzzles of class C GPCRs. Pharmacol. Ther. 130, 9–25.
doi: 10.1016/j.pharmthera.2011.01.006
Kobe, F., Renner, U., Woehler, A., Wlodarczyk, J., Papusheva, E., Bao, G., et al.
(2008). Stimulation- and palmitoylation-dependent changes in oligomeric
conformation of serotonin 5-HT1A receptors. Biochim. Biophys. Acta 1783,
1503–1516. doi: 10.1016/j.bbamcr.2008.02.021
Kobilka, B. K. (2007). G protein coupled receptor structure and activation.
Biochim. Biophys. Acta 1768, 794–807. doi: 10.1016/j.bbamem.2006.
10.021
Kralchevsky, P. A., Paunov, V. N., Denkov, N. D., and Nagayama, K. (1995).
Stresses in lipid membranes and interactions between inclusions. J. Chem. Soc.
Faraday Trans. 91, 3415–3432. doi: 10.1039/ft9959103415
Larisch, N., Kirsch, S. A., Schambony, A., Studtrucker, T., Böckmann, R. A., and
Dietrich, P. (2016). The function of the two-pore channel TPC1 depends on
dimerization of its carboxy-terminal helix. Cell. Mol. Life Sci. 73, 2565–2581.
doi: 10.1007/s00018-016-2131-3
Li, L. B., Vorobyov, I., and Allen, T. W. (2012). The role of membrane thickness in
charged protein-lipid interactions. Biochim. Biophys. Acta 1818, 135–145. doi:
10.1016/j.bbamem.2011.10.026
Li-Wei, C., Can, G., De-He, Z., Qiang, W., Xue-Jun, X., Jie, C., et al.
(2002). Homodimerization of human µ-opioid receptor overexpressed in
Sf9 insect cells. Protein Pept. Lett. 9, 145–152. doi: 10.2174/09298660234
08850
Liu, J. J., Horst, R., Katritch, V., Stevens, R. C., and Wüthrich, K. (2012a). Biased
signaling pathways in β2-adrenergic receptor characterized by 19F-NMR.
Science 335, 1106–1110. doi: 10.1126/science.1215802
Liu, W., Chun, E., Thompson, A. A., Chubukov, P., Xu, F., Katritch, V., et al.
(2012b). Structural basis for allosteric regulation of GPCRs by sodium ions.
Science 337, 232–236. doi: 10.1126/science.1219218
Lohse, M., Nuber, S., and Hoffmann, C. (2012). Fluorescence/bioluminescence
resonance energy transfer techniques to study G-protein-coupled
receptor activation and signaling. Pharmacol. Rev. 64, 299–336. doi:
10.1124/pr.110.004309
Lyman, E., Higgs, C., Kim, B., Lupyan, D., Shelley, J. C., Farid, R., et al.
(2009). A role for a specific cholesterol interaction in stabilizing the Apo
configuration of the human A2A adenosine receptor. Structure 17, 1660–1668.
doi: 10.1016/j.str.2009.10.010
Mancia, F., Assur, Z., Herman, A. G., Siegel, R., and Hendrickson, W. A. (2008).
Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptor.
EMBO Rep. 9, 363–369. doi: 10.1038/embor.2008.27
Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M.,
Sunahara, R. K., et al. (2012). Crystal structure of the µ-opioid receptor
bound to a morphinan antagonist. Nature 485, 321–326. doi: 10.1038/
nature10954
Marrink, S. J., de Vries, A. H., and Mark, A. E. (2004). Coarse grained model
for semiquantitative lipid simulations. J. Phys. Chem. B 108, 750–760. doi:
10.1021/jp036508g
Marrink, S. J., Risselada, H. J., Yefimov, S., Tieleman, D. P., and de Vries, A. H.
(2007). The MARTINI force field: Coarse grained model for biomolecular
simulations. J. Phys. Chem. B 111, 7812–7824. doi: 10.1021/jp071097f
Marrink, S. J., and Tieleman, D. P. (2013). Perspective on theMartini model.Chem.
Soc. Rev. 42, 6801–6822. doi: 10.1039/c3cs60093a
Meng, X. Y., Mezei, M., and Cui, M. (2014). Computational approaches for
modeling GPCR dimerization. Curr. Pharm. Biotechnol. 15, 996–1006. doi:
10.2174/1389201015666141013102515
Mitchell, D. C., and Litman, B. J. (1998). Molecular order and dynamics in
bilayers consisting of highly polyunsaturated phospholipids. Biophys. J. 74(2 Pt
1):879–891. doi: 10.1016/S0006-3495(98)74011-1
Mitchell, D. C., Niu, S. L., and Litman, B. J. (2003). Enhancement of G
protein-coupled signaling by DHA phospholipids. Lipids 38, 437–443. doi:
10.1007/s11745-003-1081-1
Mondal, S., Johnston, J. M., Wang, H., Khelashvili, G., Filizola, M., andWeinstein,
H. (2013). Membrane driven spatial organization of GPCRs. Sci. Rep. 3:2909.
doi: 10.1038/srep02909
Mondal, S., Khelashvili, G., Shan, J., Andersen, O. S., and Weinstein, H. (2011).
Quantitative modeling of membrane deformations by multihelical membrane
proteins: application to G-protein coupled receptors. Biophys. J. 101, 2092–
2101. doi: 10.1016/j.bpj.2011.09.037
Monticelli, L., Kandasamy, S. K., Periole, X., Larson, R. G., Tieleman, D. P.,
and Marrink, S.-J. (2008). The martini coarse-grained force field: extension to
proteins. J. Chem. Theory Comput. 4, 819–834. doi: 10.1021/ct700324x
Mouritsen, O. G. (2013). “Membrane protein-lipid match and mismatch,” in
Comprehensive Biophysics, Vol. 5, ed E. H. Egelman (Amsterdam: Humana
Press), 245–260.
Frontiers in Physiology | www.frontiersin.org 15 October 2016 | Volume 7 | Article 494
Gahbauer and Böckmann Membrane-Mediated GPCR Oligomerization
Muth, S., Fries, A., and Gimpl, G. (2011). Cholesterol-induced conformational
changes in the oxytocin receptor. Biochem. J. 437, 541–553. doi:
10.1042/BJ20101795
Ng, S. Y., Lee, L. T., and Chow, B. K. (2012). Receptor oligomerization: from
early evidence to current understanding in class B GPCRs. Front. Endocrinol.
(Lausanne) 3:175. doi: 10.3389/fendo.2012.00175
Nguyen, D. H., and Taub, D. (2002). CXCR4 function requires membrane
cholesterol: implications for HIV infection. J. Immunol. 168, 4121–4126. doi:
10.4049/jimmunol.168.8.4121
Nguyen, D. H., and Taub, D. D. (2003). Inhibition of chemokine receptor
function by membrane cholesterol oxidation. Exp. Cell Res. 291, 36–45. doi:
10.1016/S0014-4827(03)00345-8
Niu, S. L.,Mitchell, D. C., Lim, S. Y.,Wen, Z.M., Kim,H. Y., Salem, N., et al. (2004).
Reduced G protein-coupled signaling efficiency in retinal rod outer segments
in response to n-3 fatty acid deficiency. J. Biol. Chem. 279, 31098–31104. doi:
10.1074/jbc.M404376200
Oates, J., and Watts, A. (2011). Uncovering the intimate relationship between
lipids, cholesterol and GPCR activation. Curr. Opin. Struct. Biol. 21, 802–807.
doi: 10.1016/j.sbi.2011.09.007
Ostrom, R. S., and Insel, P. A. (2004). The evolving role of lipid rafts and
caveolae in G protein-coupled receptor signaling: implications for molecular
pharmacology. Br. J. Pharmacol. 143, 235–245. doi: 10.1038/sj.bjp.0705930
Ostrom, R. S., Post, S. R., and Insel, P. A. (2000). Stoichiometry and
compartmentation in G protein-coupled receptor signaling: implications
for therapeutic interventions involving G(s). J. Pharmacol. Exp. Ther. 294,
407–412.
Paila, Y. D., Kombrabail, M., Krishnamoorthy, G., and Chattopadhyay, A. (2011).
Oligomerization of the serotonin(1A) receptor in live cells: a time-resolved
fluorescence anisotropy approach. J. Phys. Chem. B 115, 11439–11447. doi:
10.1021/jp201458h
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A.,
et al. (2000). Crystal structure of rhodopsin: a G protein-coupled receptor.
Science 289, 739–745. doi: 10.1126/science.289.5480.739
Papoucheva, E., Dumuis, A., Sebben, M., Richter, D. W., and Ponimaskin, E. G.
(2004). The 5-hydroxytryptamine(1A) receptor is stably palmitoylated, and
acylation is critical for communication of receptor with Gi protein. J. Biol.
Chem. 279, 3280–3291. doi: 10.1074/jbc.M308177200
Pawson, A. J., Maudsley, S. R., Lopes, J., Katz, A. A., Sun, Y. M., Davidson, J. S.,
et al. (2003). Multiple determinants for rapid agonist-induced internalization
of a nonmammalian gonadotropin-releasing hormone receptor: a putative
palmitoylation site and threonine doublet within the carboxyl-terminal tail Are
critical. Endocrinology 144, 3860–3871. doi: 10.1210/en.2003-0028
Percherancier, Y., Berchiche, Y. A., Slight, I., Volkmer-Engert, R., Tamamura,
H., Fujii, N., et al. (2005). Bioluminescence resonance energy transfer
reveals ligand-induced conformational changes in CXCR4 homo-
and heterodimers. J. Biol. Chem. 280, 9895–9903. doi: 10.1210/en.
2003-0028
Perez-Aguilar, J. M., Shan, J., LeVine, M. V., Khelashvili, G., and Weinstein, H.
(2014). A functional selectivity mechanism at the serotonin-2A GPCR involves
ligand-dependent conformations of intracellular loop 2. J. Am. Chem. Soc. 136,
16044–16054. doi: 10.1021/ja508394x
Periole, X., Huber, T., Marrink, S. J., and Sakmar, T. P. (2007). G protein-coupled
receptors self-assemble in dynamics simulations of model bilayers. J. Am.
Chem. Soc. 129, 10126–10132. doi: 10.1021/ja0706246
Pioszak, A. A., and Xu, H. E. (2008). Molecular recognition of parathyroid
hormone by its G protein-coupled receptor. Proc. Natl. Acad. Sci. U.S.A. 105,
5034–5039. doi: 10.1073/pnas.0801027105
Pitman, M. C., Grossfield, A., Suits, F., and Feller, S. E. (2005). Role of cholesterol
and polyunsaturated chains in lipid-protein interactions: molecular dynamics
simulation of rhodopsin in a realistic membrane environment. J. Am. Chem.
Soc. 127, 4576–4577. doi: 10.1021/ja042715y
Pluhackova, K., and Böckmann, R. A. (2015). Biomembranes in atomistic
and coarse-grained simulations. J. Phys. Condens. Matter 27:323103. doi:
10.1088/0953-8984/27/32/323103
Pluhackova, K., Gahbauer, S., Kranz, F., Wassenaar, T. A., Böckmann, R. A. (2016).
Dynamic cholesterol-conditioned dimerization of the G protein coupled
chemokine receptor type 4. PLoS Comput. Biol. 12:e1005169.
Pluhackova, K., Wassenaar, T. A., and Böckmann, R. A. (2013). “Molecular
dynamics simulations of membrane proteins,” inMembrane Biogenesis, Volume
1033 of Methods in Molecular Biology, eds D. Rapaport and J. M. Herrmann
(New York, NY: Humana Press), 85–101.
Pluhackova, K., Wassenaar, T. A., Kirsch, S. A., and Böckmann, R. A. (2015).
Spontaneous adsorption of coiled-coil model peptides K and E to a mixed lipid
bilayer. J. Phys. Chem. B 119, 4396–4408. doi: 10.1021/acs.jpcb.5b00434
Ponimaskin, E. G., Heine, M., Joubert, L., Sebben, M., Bickmeyer, U., Richter,
D. W., et al. (2002). The 5-hydroxytryptamine(4a) receptor is palmitoylated
at two different sites, and acylation is critically involved in regulation
of receptor constitutive activity. J. Biol. Chem. 277, 2534–2546. doi:
10.1074/jbc.M106529200
Pontier, S. M., Percherancier, Y., Galandrin, S., Breit, A., Gales, C., and
Bouvier, M. (2008). Cholesterol-dependent separation of the β2-adrenergic
receptor from its partners determines signaling efficacy: insight into nanoscale
organization of signal transduction. J. Biol. Chem. 283, 24659–24672. doi:
10.1074/jbc.M800778200
Prakash, A., Janosi, L., and Doxastakis, M. (2010). Self-association of models of
transmembrane domains of ErbB receptors in a lipid bilayer. Biophys. J. 99,
3657–3665. doi: 10.1016/j.bpj.2010.10.023
Prasanna, X., Chattopadhyay, A., and Sengupta, D. (2014). Cholesterol modulates
the dimer interface of the β2-adrenergic receptor via cholesterol occupancy
sites. Biophys. J. 106, 1290–1300. doi: 10.1016/j.bpj.2014.02.002
Prinster, S. C., Hague, C., and Hall, R. A. (2005). Heterodimerization of G protein-
coupled receptors: specificity and functional significance. Pharmacol. Rev. 57,
289–298. doi: 10.1124/pr.57.3.1
Provasi, D., Boz, M. B., Johnston, J. M., and Filizola, M. (2015). Preferred
supramolecular organization and dimer interfaces of opioid receptors
from simulated self-association. PLoS Comput. Biol. 11:e1004148. doi:
10.1371/journal.pcbi.1004148
Qanbar, R., and Bouvier, M. (2003). Role of palmitoylation/depalmitoylation
reactions in G-protein-coupled receptor function. Pharmacol. Ther. 97, 1–33.
doi: 10.1016/S0163-7258(02)00300-5
Qiu, Y., Wang, Y., Law, P. Y., Chen, H. Z., and Loh, H. H. (2011). Cholesterol
regulates µ-opioid receptor-induced β-arrestin 2 translocation to membrane
lipid rafts.Mol. Pharmacol. 80, 210–218. doi: 10.1124/mol.110.070870
Rasmussen, S. G., Choi, H. J., Rosenbaum, D. M., Kobilka, T. S., Thian, F. S.,
Edwards, P. C., et al. (2007). Crystal structure of the human β2 adrenergic
G-protein-coupled receptor. Nature 450, 383–387. doi: 10.1038/nature06325
Renner, U., Glebov, K., Lang, T., Papusheva, E., Balakrishnan, S., Keller, B., et al.
(2007). Localization of the mouse 5-hydroxytryptamine(1A) receptor in lipid
microdomains depends on its palmitoylation and is involved in receptor-
mediated signaling. Mol. Pharmacol. 72, 502–513. doi: 10.1124/mol.107.
037085
Rog, T., and Vattulainen, I. (2014). Cholesterol, sphingolipids, and glycolipids:
what do we know about their role in raft-like membranes? Chem. Phys. Lipids
184, 82–104. doi: 10.1016/j.chemphyslip.2014.10.004
Rosenbaum, D. M., Rasmussen, S. G. F., and Kobilka, B. K. (2009). The structure
and function of G-protein-coupled receptors. Nature 459, 356–363. doi:
10.1038/nature08144
Sabbadin, D., Ciancetta, A., and Moro, S. (2014). Bridging molecular docking to
membrane molecular dynamics to investigate GPCR-ligand recognition: the
human A2A adenosine receptor as a key study. J. Chem. Inf. Model 54, 169–183.
doi: 10.1021/ci400532b
Sabourin, T., Bastien, L., Bachvarov, D. R., and Marceau, F. (2002). Agonist-
induced translocation of the kinin B(1) receptor to caveolae-related rafts. Mol.
Pharmacol. 61, 546–553. doi: 10.1124/mol.61.3.546
Sadiq, S. K., Guixa-Gonzalez, R., Dainese, E., Pastor, M., De Fabritiis, G.,
and Selent, J. (2013). Molecular modeling and simulation of membrane
lipid-mediated effects on GPCRs. Curr. Med. Chem. 20, 22–38. doi:
10.2174/0929867311320010004
Salahpour, A., Bonin, H., Bhalla, S., Petaja-Repo, U., and Bouvier, M. (2003).
Biochemical characterization of β2-adrenergic receptor dimers and oligomers.
Biol. Chem. 384, 117–123. doi: 10.1515/BC.2003.012
Salom, D., Padayatti, P. S., and Palczewski, K. (2013). Crystallization of G protein-
coupled receptors. Methods Cell Biol. 117, 451–468. doi: 10.1016/B978-0-12-
408143-7.00024-4
Frontiers in Physiology | www.frontiersin.org 16 October 2016 | Volume 7 | Article 494
Gahbauer and Böckmann Membrane-Mediated GPCR Oligomerization
Sandoval, A., Eichler, S., Madathil, S., Reeves, P. J., Fahmy, K., and Böckmann, R. A.
(2016). The molecular switching mechanism at the conserved D(E)RY motif in
class-A GPCRs. Biophys. J. 111, 79–89. doi: 10.1016/j.bpj.2016.06.004
Savi, P., Zachayus, J. L., Delesque-Touchard, N., Labouret, C., Hervé, C., Uzabiaga,
M. F., et al. (2006). The active metabolite of Clopidogrel disrupts P2Y12
receptor oligomers and partitions them out of lipid rafts. Proc. Natl. Acad. Sci.
U.S.A. 103, 11069–11074. doi: 10.1073/pnas.0510446103
Schneider, E. H., Schnell, D., Strasser, A., Dove, S., and Seifert, R. (2010). Impact
of the DRY motif and the missing “ionic lock” on constitutive activity and G-
protein coupling of the human histamine H4 receptor. J. Pharmacol. Exp. Ther.
333, 382–392. doi: 10.1124/jpet.109.163220
Schwencke, C., Okumura, S., Yamamoto, M., Geng, Y. J., and Ishikawa, Y. (1999).
Colocalization of β-adrenergic receptors and caveolin within the plasma
membrane. J. Cell. Biochem. 75, 64–72.
Sekar, R. B., and Periasamy, A. (2003). Fluorescence resonance energy transfer
(FRET) microscopy imaging of live cell protein localizations. J. Cell Biol. 160,
629–633. doi: 10.1083/jcb.200210140
Sengupta, D., and Chattopadhyay, A. (2012). Identification of cholesterol binding
sites in the serotonin1A receptor. J. Phys. Chem. B 116, 12991–12996. doi:
10.1021/jp309888u
Sengupta, D., and Chattopadhyay, A. (2015). Molecular dynamics simulations of
GPCR-cholesterol interaction: an emerging paradigm. Biochim. Biophys. Acta
1848, 1775–1782. doi: 10.1016/j.bbamem.2015.03.018
Shimomura, O., Johnson, F. H., and Saiga, Y. (1962). Extraction, purification
and properties of aequorin, a bioluminescent protein from the luminous
hydromedusan, Aequorea. J. Cell. Comp. Physiol. 59, 223–239. doi:
10.1002/jcp.1030590302
Stark, A. C., Andrews, C. T., and Elcock, A. H. (2013). Toward optimized
potential functions for protein–protein interactions in aqueous solutions:
osmotic second virial coefficient calculations using the martini coarse-
grained force field. J. Chem. Theory Comput. 9, 4176–4185. doi: 10.1021/ct40
0008p
Szidonya, L., Cserzo, M., and Hunyady, L. (2008). Dimerization and
oligomerization of G-protein-coupled receptors: debated structures with
established and emerging functions. J. Endocrinol. 196, 435–453. doi:
10.1677/JOE-07-0573
Tautermann, C. S., Seeliger, D., and Kriegl, J. M. (2015). What can we learn
from molecular dynamics simulations for GPCR drug design? Comput. Struct.
Biotechnol. J. 13, 111–121. doi: 10.1016/j.csbj.2014.12.002
Vafabakhsh, R., Levitz, J., and Isacoff, E. Y. (2015). Conformational dynamics
of a class C G-protein-coupled receptor. Nature 524, 497–501. doi:
10.1038/nature14679
Villar, V. A. M., Cuevas, S., Zheng, X., and Jose, P. A. (2016). “Chapter 1 -
Localization and signaling of GPCRs in lipid rafts,” in G Protein-Coupled
Receptors: Signaling, Trafficking and Regulation, Volume 132 ofMethods in Cell
Biology, ed A. K. Shukla (Amsterdam: Academic Press), 3–23.
Vischer, H. F., Castro, M., and Pin, J. P. (2015). G protein-coupled receptor
multimers: a question still open despite the use of novel approaches. Mol.
Pharmacol. 88, 561–571. doi: 10.1124/mol.115.099440
Wachter, R. M., Yarbrough, D., Kallio, K., and Remington, S. J. (2000).
Crystallographic and energetic analysis of binding of selected anions to the
yellow variants of green fluorescent protein. J. Mol. Biol. 301, 157–171. doi:
10.1006/jmbi.2000.3905
Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X. P., Vardy, E., et al.
(2013). Structural features for functional selectivity at serotonin receptors.
Science 340, 615–619. doi: 10.1126/science.1232808
Wang, J., He, L., Combs, C. A., Roderiquez, G., and Norcross, M. A. (2006).
Dimerization of CXCR4 in living malignant cells: control of cell migration by
a synthetic peptide that reduces homologous CXCR4 interactions.Mol. Cancer
Ther. 5, 2474–2483. doi: 10.1158/1535-7163.MCT-05-0261
Wassenaar, T. A., Ingólfsson, H. I., Böckmann, R. A., Tieleman, D. P., and
Marrink, S. J. (2015a). Computational lipidomics with insane: a versatile tool
for generating custom membranes for molecular simulations. J. Chem. Theory
Comput. 11, 2144–2155. doi: 10.1021/acs.jctc.5b00209
Wassenaar, T. A., Pluhackova, K., Moussatova, A., Sengupta, D., Marrink, S. J.,
Tieleman, D. P., et al. (2015b). High-throughput simulations of dimer and
trimer assembly of membrane proteins. The DAFT approach. J. Chem. Theory
Comput. 11, 2278–2291. doi: 10.1021/ct5010092
Whorton, M. R., Bokoch, M. P., Rasmussen, S. G., Huang, B., Zare, R. N., Kobilka,
B., et al. (2007). A monomeric G protein-coupled receptor isolated in a high-
density lipoprotein particle efficiently activates its G protein. Proc. Natl. Acad.
Sci. U.S.A. 104, 7682–7687. doi: 10.1073/pnas.0611448104
Wu, B., Chien, E. Y., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., et al. (2010).
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic
peptide antagonists. Science 330, 1066–1071. doi: 10.1126/science.1194396
Wu, H., Wang, C., Gregory, K. J., Han, G. W., Cho, H. P., Xia, Y., et al. (2014).
Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an
allosteric modulator. Science 344, 58–64. doi: 10.1126/science.1249489
Xiang, Y., Rybin, V. O., Steinberg, S. F., and Kobilka, B. (2002). Caveolar
localization dictates physiologic signaling of β2-adrenoceptors in
neonatal cardiac myocytes. J. Biol. Chem. 277, 34280–34286. doi:
10.1074/jbc.M201644200
Xu, W., Yoon, S. I., Huang, P., Wang, Y., Chen, C., Chong, P. L., et al. (2006).
Localization of the κ opioid receptor in lipid rafts. J. Pharmacol. Exp. Ther. 317,
1295–1306. doi: 10.1124/jpet.105.099507
Zezula, J., and Freissmuth, M. (2008). The A2A-adenosine receptor: a GPCR
with unique features? Br. J. Pharmacol. 153(Suppl. 1):S184–S190. doi:
10.1038/sj.bjp.0707674
Zhang, D., Gao, Z. G., Zhang, K., Kiselev, E., Crane, S., Wang, J., et al. (2015).
Two disparate ligand-binding sites in the human P2Y1 receptor. Nature 520,
317–321. doi: 10.1038/nature14287
Zhang, K., Zhang, J., Gao, Z. G., Zhang, D., Zhu, L., Han, G. W., et al. (2014).
Structure of the human P2Y12 receptor in complex with an antithrombotic
drug. Nature 509, 115–118. doi: 10.1038/nature13083
Zheng, H., Pearsall, E. A., Hurst, D. P., Zhang, Y., Chu, J., Zhou, Y.,
et al. (2012a). Palmitoylation and membrane cholesterol stabilize µ-opioid
receptor homodimerization and G protein coupling. BMC Cell Biol. 13:6. doi:
10.1186/1471-2121-13-6
Zheng, H., Zou, H., Liu, X., Chu, J., Zhou, Y., Loh, H. H., et al. (2012b). Cholesterol
level influences opioid signaling in cell models and analgesia in mice and
humans. J. Lipid Res. 53, 1153–1162. doi: 10.1194/jlr.M024455
Zocher, M., Zhang, C., Rasmussen, S. G., Kobilka, B. K., and Muller, D. J. (2012).
Cholesterol increases kinetic, energetic, and mechanical stability of the human
β2-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 109, E3463–E3472. doi:
10.1073/pnas.1210373109
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Gahbauer and Böckmann. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 17 October 2016 | Volume 7 | Article 494
